Serum markers of pulmonary epithelial damage in systemic sclerosis-associated interstitial lung disease and disease progression.
Carmel J W StockRachel K HoylesCecile DaccordMaria KokosiDina ViscaAngelo De LauretisVeronica AlfieriVasilis KouranosGeorge MargaritopoulosPeter M GeorgePhilip L MolyneauxFelix ChuaToby M MaherDavid J AbrahamVoon OngJackie DonovanPiersante SestiniChristopher P DentonAthol U WellsElisabetta A RenzoniPublished in: Respirology (Carlton, Vic.) (2020)
Our results suggest serum KL-6 predicts decline in lung function in SSc, suggesting its clinical utility in risk stratification for progressive SSc-ILD.